Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Myeloid 3Lymphoid 3CNS 3Thoracic 2Sarcoma 2Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1NET 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 135Fluorouracil 129Gemcitabine 114Bevacizumab 111Specimen Handling 101Leucovorin 101Capecitabine 87Magnetic Resonance Spectroscopy 81pembrolizumab 78Cisplatin 74Nivolumab 70Irinotecan 68Cetuximab 58130-nm albumin-bound paclitaxel 58durvalumab 57Paclitaxel 57Biopsy 55atezolizumab 42Radiotherapy 40Albumin-Bound Paclitaxel 36Taxes 35Folfox protocol 34Carboplatin 34Drug Therapy 28lenvatinib 27sintilimab 26dehydroftorafur 26Radiation 26Cyclophosphamide 26tislelizumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Photons × Gastrointestinal × 90 days × Clear all
NCT05863195 2026-06-01

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Eastern Cooperative Oncology Group

Phase 3 Recruiting
408 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03896646 2026-05-22

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03403049 2026-04-13

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Montefiore Medical Center

Phase 1 Completed
14 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT07511504 2026-04-06

Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma

OHSU Knight Cancer Institute

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡